MA53828A - Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes - Google Patents
Compositions et méthodes pour le traitement d'infections pathogènes dans des plantesInfo
- Publication number
- MA53828A MA53828A MA053828A MA53828A MA53828A MA 53828 A MA53828 A MA 53828A MA 053828 A MA053828 A MA 053828A MA 53828 A MA53828 A MA 53828A MA 53828 A MA53828 A MA 53828A
- Authority
- MA
- Morocco
- Prior art keywords
- plants
- compositions
- methods
- pathogenic infections
- treating pathogenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H3/00—Processes for modifying phenotypes, e.g. symbiosis with bacteria
- A01H3/04—Processes for modifying phenotypes, e.g. symbiosis with bacteria by treatment with chemicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8239—Externally regulated expression systems pathogen inducible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Environmental Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/148,848 US20200102356A1 (en) | 2018-10-01 | 2018-10-01 | Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants |
Publications (1)
Publication Number | Publication Date |
---|---|
MA53828A true MA53828A (fr) | 2022-01-05 |
Family
ID=69945419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA053828A MA53828A (fr) | 2018-10-01 | 2019-10-01 | Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes |
Country Status (8)
Country | Link |
---|---|
US (1) | US20200102356A1 (fr) |
EP (1) | EP3860619A4 (fr) |
CN (1) | CN113164513A (fr) |
AU (1) | AU2019351903A1 (fr) |
BR (1) | BR112021006310A2 (fr) |
MA (1) | MA53828A (fr) |
MX (1) | MX2021003849A (fr) |
WO (1) | WO2020072535A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112640711B (zh) * | 2020-12-24 | 2022-09-20 | 深圳市硒惠农生物科技有限公司 | 一种防治柚子树黄龙病的方法 |
CN113402613B (zh) * | 2021-01-19 | 2022-06-14 | 东北农业大学 | 抗菌肽ll37活性中心衍生肽二倍体抗菌肽lg及其制备方法和应用 |
WO2023018876A2 (fr) * | 2021-08-11 | 2023-02-16 | The Regents Of The University Of California | Peptides pour membranes conservant une fonction barrière |
CN114573672B (zh) * | 2022-03-21 | 2022-10-04 | 中国农业科学院农业基因组研究所 | 西瓜苦味物质葫芦素e的转运蛋白及其应用 |
WO2023201129A1 (fr) * | 2022-04-12 | 2023-10-19 | NMC Inc. | Peptides chimériques antibactériens et leurs méthodes d'utilisation thérapeutique |
CN116715733A (zh) * | 2022-10-18 | 2023-09-08 | 深圳润康生态环境股份有限公司 | 一种有效抑制柑橘黄龙病病原菌增殖的抗菌肽stj-2及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08511007A (ja) * | 1993-06-09 | 1996-11-19 | コノート ラボラトリーズ リミテッド | タンデム合成hiv−1ペプチド |
US8212110B2 (en) * | 2003-05-14 | 2012-07-03 | Integrated Plant Genetics, Inc. | Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria |
EP1629083A2 (fr) * | 2003-05-14 | 2006-03-01 | Integrated Plant Genetics, Inc. | Identification et utilisation de genes codant des proteines holines et du type holine dans les plantes pour lutter contre les microbes et les parasites |
US9181310B2 (en) * | 2003-05-14 | 2015-11-10 | University Of Florida Research Foundation, Inc. | Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria |
WO2005019242A2 (fr) * | 2003-08-18 | 2005-03-03 | E.I. Dupont De Nemours And Company | Expression de recombinaison du peptide hag1 anti-microbien: utilisation en tant que partenaire de fusion pour l'expression de peptides alpha helicoidaux antimicrobiens |
JP2007530697A (ja) * | 2004-03-29 | 2007-11-01 | ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティー・オブ・アリゾナ | 両親媒性グリコペプチド |
WO2006044596A2 (fr) * | 2004-10-15 | 2006-04-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Peptides helicoidaux amphipathiques a plusieurs domaines et leurs methodes d'utilisation |
EP1848265A2 (fr) * | 2005-01-26 | 2007-10-31 | Washington State University Research Foundation | Peptides signal pour la defense de plantes |
AU2007307254A1 (en) * | 2006-10-05 | 2008-04-17 | New York Blood Center, Inc. | Stabilized therapeutic small helical antiviral peptides |
CA2671358A1 (fr) * | 2006-12-21 | 2008-07-03 | Rickey P. Hicks | Composes peptidomimetiques antimicrobiens et procedes d'evaluation d'activite antimicrobienne |
WO2008083493A1 (fr) * | 2007-01-10 | 2008-07-17 | University Of Saskatchewan | Stabilisation de structures de peptides cycliques |
JP2010516688A (ja) * | 2007-01-16 | 2010-05-20 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 抗菌ペプチド |
GB0821687D0 (en) * | 2008-11-28 | 2008-12-31 | Secr Defence | Peptides |
WO2011049914A2 (fr) * | 2009-10-22 | 2011-04-28 | Board Of Regents Of The University Of Nebraska | Peptides anti-vih et méthodes d'utilisation |
US20160229894A1 (en) * | 2013-10-17 | 2016-08-11 | Seoul National University R&Db Foundation | Alpha helix cell-penetrating peptide multimer, preparation method therefor and use therefor |
CN107106638A (zh) * | 2014-10-14 | 2017-08-29 | 激流生物科学有限公司 | 具有抗炎特性的肽 |
JP6964577B2 (ja) * | 2015-03-23 | 2021-11-10 | リップタイド バイオサイエンス インコーポレイテッド | 抗菌性ペプチド及びその使用方法 |
US10611799B2 (en) * | 2017-03-03 | 2020-04-07 | National Tsing Hua University | Anti-endotoxin polypeptide |
-
2018
- 2018-10-01 US US16/148,848 patent/US20200102356A1/en active Pending
-
2019
- 2019-10-01 WO PCT/US2019/054131 patent/WO2020072535A1/fr unknown
- 2019-10-01 MA MA053828A patent/MA53828A/fr unknown
- 2019-10-01 AU AU2019351903A patent/AU2019351903A1/en active Pending
- 2019-10-01 MX MX2021003849A patent/MX2021003849A/es unknown
- 2019-10-01 EP EP19868297.3A patent/EP3860619A4/fr active Pending
- 2019-10-01 CN CN201980078003.8A patent/CN113164513A/zh active Pending
- 2019-10-01 BR BR112021006310-2A patent/BR112021006310A2/pt unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020072535A1 (fr) | 2020-04-09 |
US20200102356A1 (en) | 2020-04-02 |
CN113164513A (zh) | 2021-07-23 |
BR112021006310A2 (pt) | 2021-08-31 |
MX2021003849A (es) | 2021-09-08 |
AU2019351903A1 (en) | 2021-05-13 |
EP3860619A1 (fr) | 2021-08-11 |
EP3860619A4 (fr) | 2022-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA53828A (fr) | Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes | |
MA52232A (fr) | Inhibiteurs hétérobicycliques de mat2a et leurs méthodes d'utilisation pour le traitement du cancer | |
MA53558A (fr) | Compositions et procédés pour le traitement d'infections virales | |
MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
MA52861A (fr) | Méthodes et compositions pour le traitement de l'apnée du sommeil | |
MA52631A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
MA49069A (fr) | Procédés et compositions pour le traitement d'apnée du sommeil | |
MA47504A (fr) | Composés et méthodes de traitement de l'angiocholite biliaire primitive | |
MA43811A (fr) | Composés d'arylmonobactame bicycliques et leurs méthodes d'utilisation pour le traitement des infections bactériennes | |
MA51873A (fr) | Molécules probiotiques pour réduire la virulence d'agents pathogènes | |
MA44737A (fr) | Compositions pour le traitement de troubles liés à l'hyperkératose | |
MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
MA51056A (fr) | Compositions et méthodes pour le traitement d'affections métaboliques | |
MA50849A (fr) | Substances et procédés pour le traitement d'hémoglobinopathies | |
MA53329A (fr) | Méthodes de traitement de l'épilepsie | |
MA51677A (fr) | Méthodes de traitement du cancer à l'aide d'anticorps anti-pd-1 | |
MA43982A (fr) | Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1 | |
MA52971A (fr) | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle | |
MA53873A (fr) | Compositions et procédés pour le traitement de la presbytie | |
MA46750A (fr) | Méthodes de traitement de l'htap à l'aide de combinaisons de ralinepag et d'autres agents | |
MA54792A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
MA47362A (fr) | Anticorps anti-tnf, compositions et méthodes pour le traitement du rhumatisme psoriasique actif | |
MA41629A (fr) | Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité | |
MA49524A (fr) | Compositions d'antagoniste de nk-1 et méthodes destinées à être utilisées dans le traitement de la dépression | |
MA54161A (fr) | Compositions comprenant des souches bactériennes parabacteroides pour le traitement du cancer |